Akkodis unveils real-world impact of AI-led innovation across industries
From life sciences to financial services and IT operations, Akkodis demonstrates how…
Senores Pharma Reports Strong Q2 & H1 FY26 Performance, Sustains Growth Momentum Across Businesses
AHMEDABAD, India, Nov. 7, 2025 /PRNewswire/ -- Senores Pharmaceuticals Limited continued its strong…
Evergy Selects Kigen To Strengthen Grid Resilience Across Private and Public Networks
Evergy Selects Kigen's Secure eSIM OS and eIM to Maximize Grid Reliability…
SBI Life’s ‘Thanks-A-Dot’ sets a GUINNESS WORLD RECORDS, making breast health a living room conversation across communities
With a breast self-examination mosaic made of a record 1,191 'Hug of…
Thunes Powers the Next Generation of Global Money Movement with Instant Payouts in Stablecoins Across 130+ Countries
By integrating fiat and stablecoin rails in one API, Thunes sets a…
Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
October 25, 2025 11:01 ET | Source: Cullinan Therapeutics, Inc. CLN-978 led…
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium
Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM),…
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
October 24, 2025 11:39 ET | Source: PMV Pharmaceuticals, Inc. Data presented…
Joget Unlocks Autonomous Productivity Across HR, Procurement, Customer Service, and Supply Chain with No-Code AI Agent Builder
Joget AI Agent Builder enables teams across every department to create goal-driven…
Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio
Leiden, the Netherlands, October 20, 2025: Pharming Group N.V. (“Pharming” or “the Company”)…
